Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1281, 2009-01, pp. : 34-34
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Efalizumab: Guillain-Barre syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1226, 2008-01 ,pp. :
Infliximab: Guillain-Barre syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1106, 2006-01 ,pp. :
Infliximab: Guillain-Barre syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1196, 2008-01 ,pp. :
Hepatitis A vaccine: Guillain-Barre syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1323, 2010-01 ,pp. :
Oxaliplatin: First report of Guillain-Barre syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1038, 2005-01 ,pp. :